Buy or sell BostonGene stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

BostonGene Stock

BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.

About BostonGene Stock

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies

Funding History

April 2019$50.0M
April 2022$150M

Management

President & CEO

Andrew Feinberg

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo